期刊文献+

来氟米特治疗难治性肾病综合征疗效观察 被引量:8

The curative effect of leflunomide in treatment of refractory nephrotic syndrome
下载PDF
导出
摘要 目的观察来氟米特治疗难治性肾病综合征的疗效。方法32例经正规激素加环磷酰胺治疗无效的难治性肾病综合征患者。予泼尼松和来氟米特治疗12周,观察治疗前及治疗第4、8、12周尿常规、24h尿蛋白定量、血常规、肝肾功能、血脂的变化。结果治疗12周后显著降低尿蛋白含量,其中完全缓解5例,显著缓解8例,部分缓解13例,无效6例。结论来氟米特对部分难治性肾病综合征有效。 Objective To observe the curative effect of leflunomide in treatment of refractory nephrotic syndrome. Methods 32 patients with refractory nephrotic syndrome failed after standard regimen of prednisone and cyclophosphamide were treated by prednisone and leflunomide. The changes in urine routine test, amount of urine protein, blood routine test, liver and kidney function examination and serum level of lipids were examined before treatment and in 4th, 8th and 12th week after treatment. Results The amount of urinary protein was significantly decreased in all patients after treatment for 12 weeks, and complete remission was seen in 5 cases, significant remission in 8 cases, partial remission in 13 cases and failure in 6 cases. Conclusion Leflunomide is partially effective in treating cases of refractory nephrotie syndrome.
出处 《临床和实验医学杂志》 2008年第12期18-19,共2页 Journal of Clinical and Experimental Medicine
关键词 来氟米特 难治性肾病综合征 治疗 Leflunomide Refractory nephrotic syndrome Treatment
  • 相关文献

参考文献4

二级参考文献20

  • 1朱乃金,胡宗华,周湘,胡宗元.两种肾损伤诊断试剂的合成及肾损伤的动态监测[J].吉林医学,2004,25(6):9-11. 被引量:5
  • 2劳志英,倪立青,张之澧,周嘉陵,陈丽华,刘大栋.芍药总甙和甲氨蝶呤治疗类风湿关节炎的疗效和安全性[J].新药与临床,1995,14(4):194-197. 被引量:13
  • 3劳志英.长期应用雷公藤多甙治疗类风湿关节炎的不良反应[J].新药与临床,1997,16(1):36-36. 被引量:19
  • 4张凤山 赵阴环 孙铀 等.来氟米特治疗31例狼疮性肾炎的临床观察[J].临床肾病杂志,1997,24:168-168.
  • 5Choi MJ,Eustsce JA, Gimenez LF, et al. Mycophenlate mofetil treatment for primary glomerular diseases[J]. Kidney Int,2002;61:1098.
  • 6Finnegan A, Siemasko KF,Williams Jw,et al. Leflunomide inhibits immunoglobin production by two separate mechanism [J].ACR Poster Session, 1997:40.
  • 7Barlett R R. Leflunomide,an immunorestoring drug for the therapy autoimmune disorders,especially rheumatoid [J]. Current Opinion in Rheumatoid, 1997; 9: 410.
  • 8Dimitrora P,Skapenko A,Schleyerbach R.Immunomodulatory functions of leflunomide: inhibition of Th1 cell activation and promotion of Th2 differentiation [J]. Arthritis Rheum,2001;44(suppl):S216.
  • 9Petera P,Manger B,Manger K,et al.A pilot study of leflunomide in systemic lupus erythematosus [J]. Arthritis Rheum,2000 ;43(suppl):241.
  • 10Schena FP. Primary glomerulonephritis with nephritic syndrome. Limitations of therapy in adult patients [J]. J Nephrol,1999; 12(Suppl2): S125.

共引文献93

同被引文献42

引证文献8

二级引证文献42

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部